20 (AIDX) Receivables (2024 - 2026)

20 posted quarterly Receivables of $201481.0 for Q1 2026, up 0.76% on a QoQ basis from $199954.0 in Q4 2025.

20 (AIDX) has 3 years of Receivables data on file, last reported at $201481.0 in Q1 2026.

  • For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $201481.0; the trailing twelve-month figure through Mar 2026 stood at $201481.0 (changed N/A YoY), and the FY2025 full-year result was $199954.0, up 47.82% from the prior year.
  • Receivables for Q1 2026 stood at $201481.0, up from $199954.0 in the prior quarter.
  • Across five years, Receivables topped out at $201481.0 in Q1 2026 and bottomed at $135272.0 in Q4 2024.
  • The 3-year median for Receivables is $199954.0 (2025), against an average of $178902.3.
  • Peak annual rise in Receivables reached 47.82% in 2025, while the deepest fall reached 47.82% in 2025.
  • A 3-year view of Receivables shows it stood at $135272.0 in 2024, then soared by 47.82% to $199954.0 in 2025, then advanced by 0.76% to $201481.0 in 2026.
  • The last three Receivables figures came in at $201481.0 (Q1 2026), $199954.0 (Q4 2025), and $135272.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 20 - - 62,884.00 201,481.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 201,481.00
Dec 31, 2025 199,954.00
Dec 31, 2024 135,272.00